Concepedia

Author

Alice Dewdney

Royal Marsden HospitalORCID

Also Known As

A Dewdney, A. Dewdney, Alice Dewdney

89

Publications

658

Citations

11

H-Index

22

Concepts

All Affiliations

Royal Marsden HospitalRoyal Marsden NHS Foundation TrustWeston Park Cancer Centre
AD

About

Alice Dewdney is an author at Royal Marsden Hospital specializing in oncology, medicine, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

63

2

Pathology

4

4

63

3

Surgical Oncology

3

3

52

4

Health Sciences

2

2

30

5

Orthopaedics

1

1

11

Alice Dewdney

×

9

Publications

572

Citations

9

H-Index

YearCitations

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

Alice Dewdney, David Cunningham, Josep Tabernero,

Journal of Clinical Oncology

2012

387

TP53 Mutational Status and Cetuximab Benefit in Rectal Cancer: 5-Year Results of the EXPERT-C Trial

Francesco Sclafani, David González, David Cunningham,

JNCI Journal of the National Cancer Institute

2014

53

Correlation of bevacizumab-induced hypertension and outcome in the BOXER study, a phase II study of capecitabine, oxaliplatin (CAPOX) plus bevacizumab as peri-operative treatment in 45 patients with poor-risk colorectal liver-only metastases unsuitable for upfront resection

Alice Dewdney, David Cunningham, Yolanda Barbáchano,

British Journal of Cancer

2012

35

Metastatic Squamous Cell Carcinoma of the Anus: Time for a Shift in the Treatment Paradigm?

Alice Dewdney, Sheela Rao

ISRN Oncology

2012

22

Addressing the variation in adjuvant chemotherapy treatment for colorectal cancer: Can a regional intervention promote national change?

John Taylor, Daniel Swinson, Jenny F. Seligmann,

International Journal of Cancer

2020

17

Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer

Benoist Chibaudel, Julie Henriques, Manel Rakez,

JAMA Network Open

2020

17

EXPERT-C: A randomized, phase II European multicenter trial of neoadjuvant capecitabine plus oxaliplatin chemotherapy (CAPOX) and chemoradiation (CRT) with or without cetuximab followed by total mesorectal excision (TME) in patients with MRI-defined, high-risk rectal cancer.

Alice Dewdney, Jaume Capdevila, Bengt Glimelius,

Journal of Clinical Oncology

2011

16

EXPERT-C: A randomized phase II European multicenter trial of neoadjuvant chemotherapy (capecitabine/oxaliplatin) and chemoradiation (CRT) with or without cetuximab followed by total mesorectal excision (TME) in patients with MRI-defined high-risk rectal cancer.

Alice Dewdney, David Cunningham, Josep Tabernero,

Journal of Clinical Oncology

2011

14

A 'hot' leg: a rare case of isolated long bone metastases from cervical cancer.

Alice Dewdney, U Selvarajah

PubMed

2010

11

Page 1